Eeffects of early used zoledronic acid on lumbar spinal fusion

Chun-hai LI,Gang ZENG,Zhen-kai LOU,Wei YE,Yue DING,Jin-ke REN,Jin-chen CHEN

DOI: https://doi.org/10.3969/j.issn.1674-2591.2014.02.005

2014-01-01

Abstract:Objective To explore the effect of zoledronic acid on lumbar spinal fusion for patients with osteo-porosis .Methods From January 2010 to March 2011, 36 women with postmenopausal osteoporosis suffering from lumbar disc degenerative diseases were analyzed .All patients underwent posterior lumbar discectomy , decompression , intervertebral and posterolateral bone graft fusion and pedicle screw fixation .One to two weeks after surgery , all patients received 5 mg zoledronic acid infusion plus daily element calcium 1000 mg and vitamin D3 400 IU.Compare the ODI scores and biochemical markers of bone turnover before and 3 months、 6 months and 12 months after surgery .The chan-ges of bone mineral density before and 12 months after treatment were also compared .The solid fusion rate was analyzed . Results Thirty-six patients with an average age of 63.18 ±6.97 were followed .The ODI scores of pre-operation, 3 months , 6 months and 12 months after operation were 38.36 ±5.95 , 14.36 ±5.22 , 9.00 ±6.07 and 9.18 ±6.65 .Sig-nificant difference was achieved regarding to the ODI scores at any follow-up time compared with that of pre-operation (P<0.05).The ODI scores declined obviously 3 months and 6 months after surgery, reaching to a plateau at 6 months,showing no significance compared with the scores of 12 months after surgery .The biochemical markers of bone turnover β-C-terminal crosslink of type Ⅰcollagen (β-CTX) , Amino-terminal propeptide of type I collagen ( PINP) decreased sig-nificantly at 3 months ( P<0.05 ) , then increased slightly , remaining in the normal range of post menopause 6 and 12 months after surgery.Bone mineral density of hip and femoral neck were improved from (0.721 ±0.16) and (0.687 ± 0.19) g/cm2 to (0.746 ±0.16) and (0.714 ±0.17) g/cm2 (P<0.05).Thirty-four patients achieved solid fusion, with a fusion rate of 94.4%(34/36).Conclusion The anti-osteoporosis efficacy of zoledronic acid was significant and no negative effect was observed for lumbar spinal fusion .